GHP Investment Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9M Buy
40,765
+4,325
+12% +$1.2M 0.33% 97
2026
Q1
$10.8M Buy
36,440
+4,740
+15% +$1.41M 0.44% 80
2025
Q4
$8.66M Buy
31,700
+1,127
+4% +$306K 0.36% 97
2025
Q3
$8.26M Buy
30,573
+3,223
+12% +$877K 0.35% 99
2025
Q2
$7.54M Buy
27,350
+4,236
+18% +$1.15M 0.33% 105
2025
Q1
$6.13M Buy
23,114
+2,694
+13% +$665K 0.29% 128
2024
Q4
$4.74M Buy
20,420
+1,190
+6% +$274K 0.22% 157
2024
Q3
$4.24M Buy
19,230
+660
+4% +$137K 0.19% 166
2024
Q2
$3.65M Buy
18,570
+1,612
+10% +$333K 0.18% 171
2024
Q1
$3.65M Buy
16,958
+1,472
+10% +$309K 0.18% 177
2023
Q4
$3.26M Buy
15,486
+903
+6% +$193K 0.18% 176
2023
Q3
$3.2M Buy
14,583
+956
+7% +$190K 0.19% 164
2023
Q2
$2.8M Buy
13,627
+1,176
+9% +$217K 0.16% 188
2023
Q1
$2.38M Buy
12,451
+202
+2% +$36.5K 0.15% 197
2022
Q4
$2.06M Sell
12,249
-13
-0.1% -$2.26K 0.14% 202
2022
Q3
$2.17M Buy
12,262
+707
+6% +$140K 0.17% 191
2022
Q2
$2.37M Buy
11,555
+1,520
+15% +$322K 0.18% 183
2022
Q1
$2.39M Buy
10,035
+472
+5% +$111K 0.16% 193
2021
Q4
$2.19M Buy
9,563
+133
+1% +$29.3K 0.16% 181
2021
Q3
$1.82M Buy
9,430
+147
+2% +$29.8K 0.14% 178
2021
Q2
$1.97M Buy
9,283
+336
+4% +$70.9K 0.16% 167
2021
Q1
$1.83M Buy
8,947
+468
+6% +$92.2K 0.16% 165
2020
Q4
$1.54M Buy
8,479
+920
+12% +$156K 0.15% 167
2020
Q3
$1.26M Buy
7,559
+46
+0.6% +$7.75K 0.14% 168
2020
Q2
$1.22M Buy
7,513
+558
+8% +$100K 0.15% 165
2020
Q1
$1.2M Buy
6,955
+53
+0.8% +$10.5K 0.18% 153
2019
Q4
$1.39M Buy
6,902
+864
+14% +$177K 0.15% 176
2019
Q3
$1.28M Sell
6,038
-1,796
-23% -$375K 0.16% 167
2019
Q2
$1.52M Sell
7,834
-151
-2% -$27.8K 0.19% 154
2019
Q1
$1.31M Buy
7,985
+903
+13% +$160K 0.17% 160
2018
Q4
$1.33M Buy
7,082
+1,086
+18% +$201K 0.2% 145
2018
Q3
$1.02M Buy
5,996
+369
+7% +$62.1K 0.14% 178
2018
Q2
$922K Buy
5,627
+417
+8% +$68.1K 0.13% 181
2018
Q1
$843K Buy
5,210
+113
+2% +$18K 0.12% 187
2017
Q4
$744K Hold
5,097
0.11% 196
2017
Q3
$692K Sell
5,097
-10
-0.2% -$1.26K 0.11% 205
2017
Q2
$640K Hold
5,107
0.1% 209
2017
Q1
$607K Hold
5,107
0.1% 205
2016
Q4
$589K Buy
5,107
+22
+0.4% +$2.45K 0.11% 204
2016
Q3
$531K Hold
5,085
0.11% 201
2016
Q2
$495K Hold
5,085
0.11% 204
2016
Q1
$488K Buy
5,085
+75
+1% +$6.82K 0.11% 204
2015
Q4
$454K Hold
5,010
0.11% 201
2015
Q3
$465K Hold
5,010
0.12% 186
2015
Q2
$484K Hold
5,010
0.12% 182
2015
Q1
$474K Buy
5,010
+120
+2% +$11.1K 0.12% 178
2014
Q4
$433K Buy
4,890
+270
+6% +$22.9K 0.12% 186
2014
Q3
$369K Hold
4,620
0.11% 196
2014
Q2
$328K Buy
4,620
+630
+16% +$44.3K 0.1% 204
2014
Q1
$295K Hold
3,990
0.09% 210
2013
Q4
$313K Hold
3,990
0.1% 204
2013
Q3
$295K Hold
3,990
0.11% 208
2013
Q2
$303K Buy
+3,990
New +$262K 0.12% 192

Other funds holding CME

GHP Investment Advisors's CME Position: Q2 2026 in Review

GHP Investment Advisors increased its CME Group (CME) stake by 12% in Q2 2026, buying an estimated $1.2M and bringing the position to 40,765 shares worth $9M. The position accounts for 0.33% of the portfolio, ranked #97.

GHP Investment Advisors first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.8M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • GHP Investment Advisors held 40,765 shares of CME Group worth $9M as of Q2 2026.
  • GHP Investment Advisors bought 4,325 CME Group shares in Q2 2026, an estimated $1.2M.
  • CME Group made up 0.33% of GHP Investment Advisors's portfolio in Q2 2026, its #97 holding.
  • GHP Investment Advisors first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • GHP Investment Advisors's CME Group position peaked at $10.8M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.